naproxen has been researched along with Cancer of Prostate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bekçi, H; Birgül, K; Cumaoğlu, A; Kabasakal, L; Karasulu, E; Karasulu, HY; Küçükgüzel, ŞG; Uba, AI; Yelekçi, K; Yıldırım, Y; Yılmaz, Ö | 1 |
Feldman, D; Srinivas, S | 1 |
Andrews, J; Andrews, P; Djakiew, D; Krygier, S | 1 |
1 trial(s) available for naproxen and Cancer of Prostate
Article | Year |
---|---|
A phase II trial of calcitriol and naproxen in recurrent prostate cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Calcitriol; Humans; Male; Middle Aged; Naproxen; Prostatic Neoplasms; Recurrence | 2009 |
2 other study(ies) available for naproxen and Cancer of Prostate
Article | Year |
---|---|
Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Male; Methionyl Aminopeptidases; Mice, Nude; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Naproxen; Prostatic Neoplasms; Protein Binding; Stereoisomerism; Structure-Activity Relationship | 2020 |
Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
Topics: Acetaminophen; Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Division; Humans; Ibuprofen; In Situ Nick-End Labeling; Male; Mice; Naproxen; Nitrobenzenes; Prostatic Neoplasms; Sulfonamides; Tumor Cells, Cultured | 2002 |